Insulin, fast-acting

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC A10AB0[4-6]
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector INSULIN_FAST

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 9662 4400 5262
Unadjusted prevalence (%) 3.72 2.99 4.65
Mean age at first event (years) 43.02 40.42 45.20

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.07 4.82 [3.88, 5.98] 9.1e-46 1159
15 years 0.04 5.20 [4.22, 6.41] 4.0e-54 1039
5 years 0.01 6.34 [5.22, 7.70] 3.8e-77 420
1 year 0.00 2.22 [1.47, 3.34] 1.3e-4 28

Correlations

Index endpoint: INSULIN_FAST – Insulin, fast-acting
GWS hits:

Survival analyses between endpoints

Plot

before Insulin, fast-acting
after Insulin, fast-acting

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Insulin, fast-acting